These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19324285)

  • 21. The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy.
    Wee CC; Girotra S; Weinstein AR; Mittleman MA; Mukamal KJ
    J Am Coll Cardiol; 2008 Aug; 52(8):620-5. PubMed ID: 18702964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in cardiology.
    Menown IA; Shand JA
    Future Cardiol; 2010 Jan; 6(1):11-7. PubMed ID: 20014984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interventions to improve guideline compliance following coronary artery bypass grafting.
    Yam FK; Akers WS; Ferraris VA; Smith K; Ramaiah C; Camp P; Flynn JD
    Surgery; 2006 Oct; 140(4):541-7; discussion 547-52. PubMed ID: 17011901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing volumes, risk profiles, and outcomes of coronary artery bypass grafting and percutaneous coronary interventions.
    Aldea GS; Mokadam NA; Melford R; Stewart D; Maynard C; Reisman M; Goss R
    Ann Thorac Surg; 2009 Jun; 87(6):1828-38. PubMed ID: 19463603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current perspectives on coronary revascularization in the diabetic patient.
    Roffi M; Brandle M; Robbins MA; Mukherjee D
    Indian Heart J; 2007; 59(2):124-36. PubMed ID: 19122245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of nonlinear heart rate dynamics after beating-heart revascularization.
    Ksela J; Suwalski P; Kalisnik JM; Avbelj V; Suwalski G; Gersak B
    Heart Surg Forum; 2009 Jan; 12(1):E10-6. PubMed ID: 19233759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
    Vranckx P; Schultz CJ; Valgimigli M; Eindhoven JA; Kappetein AP; Regar ES; Van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):302-10. PubMed ID: 19360865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial.
    Husted S; Harrington RA; Cannon CP; Storey RF; Mitchell P; Emanuelsson H
    Int J Clin Pract; 2009 Apr; 63(4):667-70. PubMed ID: 19335707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Off pump total arterial revascularization--clinical and technical considerations].
    Dorobanţu LF; Lanzillo G; Cerin G; Casalino S; Stelian E; Novelli E; Diena M
    Chirurgia (Bucur); 2007; 102(5):581-4. PubMed ID: 18018360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal extracorporeal circulation and off-pump compared to conventional cardiopulmonary bypass in coronary surgery.
    Panday GF; Fischer S; Bauer A; Metz D; Schubel J; El Shouki N; Eberle T; Hausmann H
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):832-6. PubMed ID: 19671581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population.
    Wiederkehr D; Ogbonnaya A; Casciano R; Makenbaeva D; Mozaffari E; Corbelli J
    Curr Med Res Opin; 2009 Sep; 25(9):2327-34. PubMed ID: 19635046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple extensive coronary artery stenting: does it compromise future surgical revascularization?
    Al-Attar N; Nataf P
    Curr Opin Cardiol; 2007 Nov; 22(6):529-33. PubMed ID: 17921740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clopidogrel use and bleeding after coronary artery bypass graft surgery.
    Kim JH; Newby LK; Clare RM; Shaw LK; Lodge AJ; Smith PK; Jolicoeur EM; Rao SV; Becker RC; Mark DB; Granger CB
    Am Heart J; 2008 Nov; 156(5):886-92. PubMed ID: 19061702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.